BDBM286016 (E/Z)-(+/-)-N-[(1-Carbamimidoylpiperidin-4-yl)methyl]-2,10-dioxo-1,2,3,4,7,8,9,10-octahydro-1,9-benzodiazacyclododecine-8-carboxamide::US10081623, Example 29

SMILES NC(=N)N1CCC(CNC(=O)C2CC=CCCC(=O)Nc3ccccc3C(=O)N2)CC1

InChI Key InChIKey=OCXNCJQZMRSTLD-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 286016   

TargetCoagulation factor XI(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286016(US10081623, Example 29 | (E/Z)-(+/-)-N-[(1-Carbami...)
Affinity DataKi:  1.41E+3nMpH: 7.4Assay Description:The effectiveness of compounds of the present invention as inhibitors of the coagulation Factors XIa, VIIa, IXa, Xa, XIIa, plasma kallikrein or throm...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
Go to US Patent